These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 8581385)
1. Targeting lipoproteins to Fc gamma receptors with bispecific antibodies. Morganelli PM J Hematother; 1995 Oct; 4(5):457-61. PubMed ID: 8581385 [TBL] [Abstract][Full Text] [Related]
2. Enhanced metabolism of LDL aggregates mediated by specific human monocyte IgG Fc receptors. Morganelli PM; Rogers RA; Kitzmiller TJ; Bergeron A J Lipid Res; 1995 Apr; 36(4):714-24. PubMed ID: 7616118 [TBL] [Abstract][Full Text] [Related]
3. Redirected targeting of LDL to human monocyte Fc gamma receptors with bispecific antibodies. Morganelli PM; Kitzmiller TJ; Hemmer R; Fanger MW Arterioscler Thromb; 1992 Oct; 12(10):1131-8. PubMed ID: 1390585 [TBL] [Abstract][Full Text] [Related]
4. Evidence that human Fc gamma receptor IIA (CD32) subtypes are not receptors for oxidized LDL. Morganelli PM; Groveman DS; Pfeiffer JR Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3248-54. PubMed ID: 9409319 [TBL] [Abstract][Full Text] [Related]
5. Oxidized LDL immune complexes induce release of sphingosine kinase in human U937 monocytic cells. Hammad SM; Taha TA; Nareika A; Johnson KR; Lopes-Virella MF; Obeid LM Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):126-40. PubMed ID: 16516816 [TBL] [Abstract][Full Text] [Related]
6. Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies. Lopes-Virella MF; Griffith RL; Shunk KA; Virella GT Arterioscler Thromb; 1991; 11(5):1356-67. PubMed ID: 1911721 [TBL] [Abstract][Full Text] [Related]
7. The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptor. Lopes-Virella MF; Binzafar N; Rackley S; Takei A; La Via M; Virella G Atherosclerosis; 1997 Dec; 135(2):161-70. PubMed ID: 9430365 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Fc gamma receptor mediated T-cell activation by two purified CD3 x CD19 bispecific monoclonal antibodies with hybrid Fc domains. Haagen IA; Geerars AJ; Bast EJ; de Gast GC; van de Winkel JG; de Lau WB Ther Immunol; 1994 Oct; 1(5):279-87. PubMed ID: 7584502 [TBL] [Abstract][Full Text] [Related]
9. Initial trial of bispecific antibody-mediated immunotherapy of CD15-bearing tumors: cytotoxicity of human tumor cells using a bispecific antibody comprised of anti-CD15 (MoAb PM81) and anti-CD64/Fc gamma RI (MoAb 32). Ball ED; Guyre PM; Mills L; Fisher J; Dinces NB; Fanger MW J Hematother; 1992; 1(1):85-94. PubMed ID: 1365020 [TBL] [Abstract][Full Text] [Related]
10. Production and use of anti-FcR bispecific antibodies. Fanger MW; Graziano RF; Guyre PM Immunomethods; 1994 Feb; 4(1):72-81. PubMed ID: 8069530 [TBL] [Abstract][Full Text] [Related]
11. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors. Mady BJ; Erbe DV; Kurane I; Fanger MW; Ennis FA J Immunol; 1991 Nov; 147(9):3139-44. PubMed ID: 1680925 [TBL] [Abstract][Full Text] [Related]
14. Lipoprotein-antibody immune complexes. Their catabolism and role in foam cell formation. Klimov AN; Denisenko AD; Popov AV; Nagornev VA; Pleskov VM; Vinogradov AG; Denisenko TV; Magracheva EYa ; Kheifes GM; Kuznetzov AS Atherosclerosis; 1985 Dec; 58(1-3):1-15. PubMed ID: 4091875 [TBL] [Abstract][Full Text] [Related]
15. Factors influencing the endocytosis of immune complexes. van Es LA; Daha MR Adv Nephrol Necker Hosp; 1984; 13():341-67. PubMed ID: 6236677 [TBL] [Abstract][Full Text] [Related]
16. Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics. Asano R; Shimomura I; Konno S; Ito A; Masakari Y; Orimo R; Taki S; Arai K; Ogata H; Okada M; Furumoto S; Onitsuka M; Omasa T; Hayashi H; Katayose Y; Unno M; Kudo T; Umetsu M; Kumagai I MAbs; 2014; 6(5):1243-54. PubMed ID: 25517309 [TBL] [Abstract][Full Text] [Related]
17. Stimulation with a monoclonal antibody (mAb4E4) of scavenger receptor-mediated uptake of chemically modified low density lipoproteins by THP-1-derived macrophages enhances foam cell generation. Holvoet P; Perez G; Bernar H; Brouwers E; Vanloo B; Rosseneu M; Collen D J Clin Invest; 1994 Jan; 93(1):89-98. PubMed ID: 8282826 [TBL] [Abstract][Full Text] [Related]
18. Human intravenous immunoglobulin (hIVIG) inhibits anti-CD32 antibody binding to canine DH82 cells and canine monocytes in vitro. Sibley TA; Miller MM; Fogle JE Vet Immunol Immunopathol; 2013 Feb; 151(3-4):229-34. PubMed ID: 23276750 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of interferon-gamma on metabolism of lipoprotein immune complexes mediated by specific human macrophage Fcgamma receptors. Morganelli PM; Kennedy SM; Mitchell TI J Lipid Res; 2000 Mar; 41(3):405-15. PubMed ID: 10706588 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates. Khoo JC; Miller E; Pio F; Steinberg D; Witztum JL Arterioscler Thromb; 1992 Nov; 12(11):1258-66. PubMed ID: 1420085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]